HGSI/GSK's Benlysta Gets BLySfully Clean Labeling, Escaping Feared Restrictions
This article was originally published in The Pink Sheet Daily
Executive Summary
The indication is notable for what it does not contain, which is language specifically excluding African Americans or patients with severe active lupus nephritis or severe central nervous system lupus.